XML 44 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Financial Instruments (Schedule of Reconciliation of Contingent Consideration) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Contingent Consideration    
Change in valuation $ 1,740 $ (2,830)
Ascyrus Medical LLC    
Contingent Consideration    
Change in valuation 1,700 $ (2,800)
Ascyrus Medical LLC | Level 3    
Contingent Consideration    
Balance as of December 31, 2025 60,580  
Change in valuation 1,740  
Balance as of March 31, 2026 $ 62,320